Showing results (641-650 of 1,120) with videos related to

Sort By:
Pageof 112
Trials|February 6, 2021
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trialMona Aflaki, Alexandria Flannery, João Pedro Ferreira, et al.
Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Circulation|November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE TrialFrederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
American Heart Journal|October 30, 2020
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysisAnubodh S Varshney, David E Wang, Ankeet S Bhatt, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
International Journal of Molecular Sciences|October 16, 2025
Serotonergic and Cholinergic Imbalance in the Offspring of Rats Exposed to Bisphenol A and Bisphenol S During Pregnancy and Lactation: Short- and Long-Term EffectsKeila A Semeão, Ana Carolina Dutra-Tavares, Anderson Ribeiro-Carvalho, et al.
Journal of Nutrition and Metabolism|September 27, 2024
Effect of Zinc Supplementation on Body Composition of Duchenne Muscular Dystrophy Patients: A Quasi-Experimental StudyThais A Cunha, Karina M Vermeulen-Serpa, Evellyn C Grilo, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Pageof 112